CLONAZEPAM Side Effects

6680733-7 | Convulsion
on Apr 13, 2010 Male patient from UNITED STATES , weighting 196.0 lb, was diagnosed with epilepsy (What is epilepsy?) and was treated with Clonazepam (View Usage). Patient experienced the following unwanted or unexpected effects: convulsion. Clonazepam dosage: 1 Mg Bid Po 1/2 Mg Bid Po Prior To January 2007-12/09. During the same period patient was treated with CARBAMAZEPINE (200 Mg Qid Po) (View Carbamazepine Review and Carbamazepine Label ).

6676785-0 | Faecal Incontinence, Ill-defined Disorder, Senile Dementia
Patient was taking Clonazepam (View Usage). Patient had the following side effects: faecal incontinence, ill-defined disorder, senile dementia on Apr 06, 2010 from BRAZIL Additional patient health information: Female patient , weighting 125.7 lb, was diagnosed with insomnia and. Clonazepam dosage: Stop Date: 2010, 1 Tablet A Day At Night.

6672731-4 | Depression, Feeling Jittery, Malaise, Nervousness, Overdose, Panic Attack, Somnolence, Suicide Attempt, Vomiting
Adverse event was reported on Mar 30, 2010 by a Female patient taking Clonazepam (View Usage) (Dosage: ) . Location: UNITED STATES , weighting 151.9 lb, After Clonazepam was administered, patient had the following side effects: depression (What is depression?), feeling jittery, malaise, nervousness, overdose, panic attack, somnolence, suicide attempt, vomiting. During the same period patient was treated with CHANTIX (Form: Film Coated Tablet.) (View Chantix Review and Chantix Label ), ABILIFY (Start Date: 2010.) (View Abilify Review and Abilify Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), FERROUS SULFATE TAB (View Ferrous Sulfate Tab Review and Ferrous Sulfate Tab Label ), LEXAPRO (Stop Date: 2010.) (View Lexapro Review and Lexapro Label ), FLEXERIL (View Flexeril Review and Flexeril Label ). Patient was hospitalized.

6672695-3 | Diabetes Mellitus Inadequate Control, Headache, Somnolence, Therapeutic Response Decreased
on Apr 05, 2010 Female patient from BRAZIL , weighting 176.4 lb, was diagnosed with insomnia, depression (What is depression?) and was treated with Clonazepam (View Usage). Patient experienced the following unwanted or unexpected effects: diabetes mellitus inadequate control, headache (What is headache?), somnolence, therapeutic response decreased. Clonazepam dosage: 1 Tablet Of 2 Mg At Night (before Sleep). During the same period patient was treated with INSULIN (Morning And Afternoon) (View Insulin Review and Insulin Label ), DAONIL (2 Tablets On Morning And 2 Tablets On Afternoon) (View Daonil Review and Daonil Label ), ZETRON (2 Tablets In Morning) (View Zetron Review and Zetron Label ), METFORMIN (After Lunch) (View Metformin Review and Metformin Label ).


6671405-3 | Abdominal Pain Upper, Agoraphobia, Anxiety, Depression, Diarrhoea, Dyspnoea, Feeling Abnormal, Heart Rate Increased
on Apr 06, 2010 Female patient from UNITED STATES , 43 years of age, weighting 210.0 lb, was treated with Clonazepam (View Usage). Patient had the following side effects: abdominal pain upper, agoraphobia, anxiety (What is anxiety?), depression (What is depression?), diarrhoea, dyspnoea, feeling abnormal, heart rate increased. Clonazepam dosage: .

6668282-3 | Confusional State
Patient was taking Clonazepam (View Usage). After Clonazepam was administered, patient had the following side effects: confusional state on Apr 05, 2010 from UNITED STATES Additional patient health information: Male patient , 40 years of age, weighting 205.3 lb, was diagnosed with depression (What is depression?) and. Clonazepam dosage: 0.5 Mg Bid Po ; 15/30 Mg Every Day Po. Patient was hospitalized.

6667511-X | Sedation
Adverse event was reported on Apr 01, 2010 by a Male patient taking Clonazepam (View Usage) (Dosage: Strength: 2.5mg/ml, Other Indication: Anxiety And Sleep-talking) was diagnosed with insomnia and. Location: BRAZIL , 81 years of age, Patient experienced the following unwanted or unexpected effects: sedation.

6667097-X | Product Substitution Issue
on Apr 01, 2010 Female patient from UNITED STATES , weighting 145.0 lb, was diagnosed with panic disorder (What is panic disorder?) and was treated with Clonazepam (View Usage). Patient had the following side effects: product substitution issue. Clonazepam dosage: 1.5 1 Po.

6659558-4 |
on Mar 22, 2010 Female patient from UNITED STATES , 51 years of age, was treated with Clonazepam (View Usage). . Clonazepam dosage: . During the same period patient was treated with DOXEPIN (WATSON LABORATORIES) (View Doxepin (watson Laboratories) Review and Doxepin (watson Laboratories) Label ), CLONIDINE (View Clonidine Review and Clonidine Label ), DIPHENHYDRAMINE HCL (View Diphenhydramine Hcl Review and Diphenhydramine Hcl Label ), SERTRALINE HYDROCHLORIDE (View Sertraline Hydrochloride Review and Sertraline Hydrochloride Label ), OXYTROL (View Oxytrol Review and Oxytrol Label ), ETHANOL (View Ethanol Review and Ethanol Label ), SILDENAFIL CITRATE (View Sildenafil Citrate Review and Sildenafil Citrate Label ).

6654332-7 |
Patient was taking Clonazepam (View Usage). on Mar 22, 2010 from UNITED STATES Additional patient health information: Female patient , 67 years of age, . Clonazepam dosage: Unk. During the same period patient was treated with ETHANOL (View Ethanol Review and Ethanol Label ).

6654322-4 |
Adverse event was reported on Mar 22, 2010 by a Female patient taking Clonazepam (View Usage) (Dosage: ) . Location: UNITED STATES , 42 years of age, . During the same period patient was treated with ZOLPIDEM TARTRATE (View Zolpidem Tartrate Review and Zolpidem Tartrate Label ), TRAMADOL HCL (View Tramadol Hcl Review and Tramadol Hcl Label ), CYCLOBENZAPRINE HYDROCHLORIDE (View Cyclobenzaprine Hydrochloride Review and Cyclobenzaprine Hydrochloride Label ), TRAZODONE HYDROCHLORIDE (View Trazodone Hydrochloride Review and Trazodone Hydrochloride Label ), DULOXETINE HYDROCHLORIDE (View Duloxetine Hydrochloride Review and Duloxetine Hydrochloride Label ).

6654313-3 |
on Mar 22, 2010 Male patient from UNITED STATES , 34 years of age, was treated with Clonazepam (View Usage). . Clonazepam dosage: .

6654298-X |
on Mar 22, 2010 Female patient from UNITED STATES , 35 years of age, was treated with Clonazepam (View Usage). . Clonazepam dosage: . During the same period patient was treated with QUETIAPINE (View Quetiapine Review and Quetiapine Label ), LITHIUM (View Lithium Review and Lithium Label ).

6654285-1 |
Patient was taking Clonazepam (View Usage). on Mar 22, 2010 from UNITED STATES Additional patient health information: Female patient , 33 years of age, . Clonazepam dosage: . During the same period patient was treated with QUETIAPINE (View Quetiapine Review and Quetiapine Label ), COCAINE (View Cocaine Review and Cocaine Label ).

6654282-6 |
Adverse event was reported on Mar 22, 2010 by a Female patient taking Clonazepam (View Usage) (Dosage: ) . Location: UNITED STATES , 60 years of age, . During the same period patient was treated with DILTIA XT (WATSON LABORATORIES) (View Diltia Xt (watson Laboratories) Review and Diltia Xt (watson Laboratories) Label ), ZOLPIDEM TARTRATE (View Zolpidem Tartrate Review and Zolpidem Tartrate Label ).

6654259-0 |
on Mar 22, 2010 Male patient from UNITED STATES , 21 years of age, was treated with Clonazepam (View Usage). . Clonazepam dosage: . During the same period patient was treated with MIRTAZAPINE (View Mirtazapine Review and Mirtazapine Label ), CITALOPRAM HYDROBROMIDE (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ), ETHANOL (View Ethanol Review and Ethanol Label ).

6654252-8 |
on Mar 22, 2010 Female patient from UNITED STATES , 33 years of age, was treated with Clonazepam (View Usage). . Clonazepam dosage: . During the same period patient was treated with LORAZEPAM (View Lorazepam Review and Lorazepam Label ), AMITRIPTYLINE (View Amitriptyline Review and Amitriptyline Label ).

6654246-2 |
Patient was taking Clonazepam (View Usage). on Mar 22, 2010 from UNITED STATES Additional patient health information: Male patient , 48 years of age, . Clonazepam dosage: . During the same period patient was treated with HALOPERIDOL (WATSON LABORATORIES) (View Haloperidol (watson Laboratories) Review and Haloperidol (watson Laboratories) Label ), TRAZODONE HYDROCHLORIDE (View Trazodone Hydrochloride Review and Trazodone Hydrochloride Label ), VALPROIC ACID (View Valproic Acid Review and Valproic Acid Label ), BENZODIAZEPINE DERIVATIVES (View Benzodiazepine Derivatives Review and Benzodiazepine Derivatives Label ).

6654239-5 |
Adverse event was reported on Mar 22, 2010 by a Female patient taking Clonazepam (View Usage) (Dosage: ) . Location: UNITED STATES , 20 years of age, . During the same period patient was treated with PROPOXYPHENE HCL AND ACETAMINOPHEN (View Propoxyphene Hcl And Acetaminophen Review and Propoxyphene Hcl And Acetaminophen Label ), TRAZODONE HYDROCHLORIDE (View Trazodone Hydrochloride Review and Trazodone Hydrochloride Label ), ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ), HYDROCODONE BITARTRATE AND ACETAMINOPHEN (View Hydrocodone Bitartrate And Acetaminophen Review and Hydrocodone Bitartrate And Acetaminophen Label ), QUETIAPINE (View Quetiapine Review and Quetiapine Label ).

6654234-6 |
on Mar 22, 2010 Male patient from UNITED STATES , 27 years of age, was treated with Clonazepam (View Usage). . Clonazepam dosage: Unk. During the same period patient was treated with IBUPROFEN TABLETS (Unk) (View Ibuprofen Tablets Review and Ibuprofen Tablets Label ), BUPROPION HCL (Unk) (View Bupropion Hcl Review and Bupropion Hcl Label ), HYDROCODONE BITARTRATE AND ACETAMINOPHEN (Unk) (View Hydrocodone Bitartrate And Acetaminophen Review and Hydrocodone Bitartrate And Acetaminophen Label ), COMPAZINE (View Compazine Review and Compazine Label ), OLANZAPINE (View Olanzapine Review and Olanzapine Label ).

6654219-X |
on Mar 22, 2010 Female patient from UNITED STATES , 60 years of age, was treated with Clonazepam (View Usage). . Clonazepam dosage: Unk. During the same period patient was treated with FORTAMET (Unk) (View Fortamet Review and Fortamet Label ), LISINOPRIL (Unk) (View Lisinopril Review and Lisinopril Label ), SIMVASTATIN (Unk) (View Simvastatin Review and Simvastatin Label ), HALOPERIDOL (WATSON LABORATORIES) (Unk) (View Haloperidol (watson Laboratories) Review and Haloperidol (watson Laboratories) Label ), VALPROIC ACID (View Valproic Acid Review and Valproic Acid Label ), LOSARTAN POTASSIUM (View Losartan Potassium Review and Losartan Potassium Label ), CALCIUM /00009901/ (View Calcium /00009901/ Review and Calcium /00009901/ Label ).

6654216-4 |
Patient was taking Clonazepam (View Usage). on Mar 22, 2010 from UNITED STATES Additional patient health information: Male patient , 42 years of age, . Clonazepam dosage: . During the same period patient was treated with LITHIUM (View Lithium Review and Lithium Label ), OXCARBAZEPINE (View Oxcarbazepine Review and Oxcarbazepine Label ), ARIPIPRAZOLE (View Aripiprazole Review and Aripiprazole Label ).

6652350-6 |
Adverse event was reported on Mar 22, 2010 by a Female patient taking Clonazepam (View Usage) (Dosage: ) . Location: UNITED STATES , 58 years of age, . During the same period patient was treated with MORPHINE SULFATE INJ (View Morphine Sulfate Inj Review and Morphine Sulfate Inj Label ), ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ), CARISOPRODOL (WATSON LABORATORIES) (View Carisoprodol (watson Laboratories) Review and Carisoprodol (watson Laboratories) Label ), SECOBARBITAL SODIUM (View Secobarbital Sodium Review and Secobarbital Sodium Label ).

6652118-0 |
on Mar 22, 2010 Male patient from UNITED STATES , 45 years of age, was treated with Clonazepam (View Usage). . Clonazepam dosage: . During the same period patient was treated with METHADONE (View Methadone Review and Methadone Label ).

6652108-8 |
on Mar 22, 2010 Female patient from UNITED STATES , 49 years of age, was treated with Clonazepam (View Usage). . Clonazepam dosage: . During the same period patient was treated with HYDROCODONE BITARTRATE AND ACETAMINOPHEN (View Hydrocodone Bitartrate And Acetaminophen Review and Hydrocodone Bitartrate And Acetaminophen Label ), OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN (View Oxycodone Hydrochloride And Acetaminophen Review and Oxycodone Hydrochloride And Acetaminophen Label ), DILTIA XT (WATSON LABORATORIES) (View Diltia Xt (watson Laboratories) Review and Diltia Xt (watson Laboratories) Label ), TOPIRAMATE (View Topiramate Review and Topiramate Label ), ETHANOL (View Ethanol Review and Ethanol Label ).

6652103-9 |
Patient was taking Clonazepam (View Usage). on Mar 22, 2010 from UNITED STATES Additional patient health information: Female patient , 43 years of age, . Clonazepam dosage: . During the same period patient was treated with FENTANYL (View Fentanyl Review and Fentanyl Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ), ETHANOL (View Ethanol Review and Ethanol Label ), BENZODIAZEPINE DERIVATIVES (View Benzodiazepine Derivatives Review and Benzodiazepine Derivatives Label ).

6652092-7 |
Adverse event was reported on Mar 22, 2010 by a Female patient taking Clonazepam (View Usage) (Dosage: ) . Location: UNITED STATES , 40 years of age, . During the same period patient was treated with CHLORPHENIRAMINE MALEATE (View Chlorpheniramine Maleate Review and Chlorpheniramine Maleate Label ), CARBON MONOXIDE (View Carbon Monoxide Review and Carbon Monoxide Label ), OPIOID ANAESTHETICS (View Opioid Anaesthetics Review and Opioid Anaesthetics Label ), DOXYLAMINE (View Doxylamine Review and Doxylamine Label ).

6652085-X |
on Mar 22, 2010 Female patient from UNITED STATES , 22 years of age, was treated with Clonazepam (View Usage). . Clonazepam dosage: . During the same period patient was treated with OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN (View Oxycodone Hydrochloride And Acetaminophen Review and Oxycodone Hydrochloride And Acetaminophen Label ), METHADONE (View Methadone Review and Methadone Label ).

6652082-4 |
on Mar 22, 2010 Male patient from UNITED STATES , 26 years of age, was treated with Clonazepam (View Usage). . Clonazepam dosage: . During the same period patient was treated with HYDROCODONE BITARTRATE AND ACETAMINOPHEN (View Hydrocodone Bitartrate And Acetaminophen Review and Hydrocodone Bitartrate And Acetaminophen Label ).

6652077-0 |
Patient was taking Clonazepam (View Usage). on Mar 22, 2010 from UNITED STATES Additional patient health information: Female patient , 32 years of age, . Clonazepam dosage: . During the same period patient was treated with HYDROCODONE BITARTRATE + ACETAMINOPHEN (View Hydrocodone Bitartrate + Acetaminophen Review and Hydrocodone Bitartrate + Acetaminophen Label ), SODIUM SALICYLATE ECT (View Sodium Salicylate Ect Review and Sodium Salicylate Ect Label ), ETHANOL (View Ethanol Review and Ethanol Label ).

6652062-9 |
Adverse event was reported on Mar 22, 2010 by a Female patient taking Clonazepam (View Usage) (Dosage: ) . Location: UNITED STATES , 30 years of age, . During the same period patient was treated with OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN (View Oxycodone Hydrochloride And Acetaminophen Review and Oxycodone Hydrochloride And Acetaminophen Label ), ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ), METHADONE (View Methadone Review and Methadone Label ).

6652051-4 |
on Mar 22, 2010 Male patient from UNITED STATES , 27 years of age, was treated with Clonazepam (View Usage). . Clonazepam dosage: . During the same period patient was treated with MORPHINE SULFATE INJ (View Morphine Sulfate Inj Review and Morphine Sulfate Inj Label ), PROPOXYPHENE HCL (View Propoxyphene Hcl Review and Propoxyphene Hcl Label ), MARIJUANA (View Marijuana Review and Marijuana Label ).

6649422-9 | Perirectal Abscess
on Feb 25, 2010 Female patient from UNITED STATES , weighting 244.1 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Clonazepam (View Usage). After Clonazepam was administered, patient had the following side effects: perirectal abscess. Clonazepam dosage: . During the same period patient was treated with RITUXIMAB (500 Mg, Days 1+amp;15) (View Rituximab Review and Rituximab Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), BUSPAR (View Buspar Review and Buspar Label ), CYMBALTA (View Cymbalta Review and Cymbalta Label ), KEFLEX (View Keflex Review and Keflex Label ), LORTAB (View Lortab Review and Lortab Label ), MEDROL (View Medrol Review and Medrol Label ), PHENERGAN HCL (View Phenergan Hcl Review and Phenergan Hcl Label ). Patient was hospitalized.

6647674-2 | Epilepsy
Patient was taking Clonazepam (View Usage). Patient experienced the following unwanted or unexpected effects: epilepsy (What is epilepsy?) on Mar 23, 2010 from UNITED STATES Additional patient health information: Male patient , 45 years of age, weighting 160.0 lb, was diagnosed with anxiety (What is anxiety?) and. Clonazepam dosage: 0.5 3 Times A Day 3 Months Aug. Sept Oct.. During the same period patient was treated with KLONOPIN (Rph Cw2 - Tch/w/34) (View Klonopin Review and Klonopin Label ). Patient was hospitalized.

6644457-4 | Balance Disorder, Brain Injury, Convulsion, Dermal Cyst, Fall, Insomnia, Memory Impairment, Nightmare, Rib Fracture
Adverse event was reported on Mar 10, 2010 by a Male patient taking Clonazepam (View Usage) (Dosage: ) . Location: UNITED STATES , 30 years of age, weighting 190.0 lb, Patient had the following side effects: balance disorder, brain injury, convulsion, dermal cyst, fall (What is fall?), insomnia, memory impairment, nightmare, rib fracture. During the same period patient was treated with DIAZEPAM (View Diazepam Review and Diazepam Label ), CHANTIX (Form: Film Coated Tablet) (View Chantix Review and Chantix Label ), KEPPRA (View Keppra Review and Keppra Label ), SOMA (View Soma Review and Soma Label ), NEURONTIN (View Neurontin Review and Neurontin Label ), XANAX (View Xanax Review and Xanax Label ). Patient was hospitalized.

6642385-1 | Brugada Syndrome, Coma, Hypotension, Hypoventilation
on Mar 15, 2010 Female patient from UNITED STATES , 34 years of age, was treated with Clonazepam (View Usage). After Clonazepam was administered, patient had the following side effects: brugada syndrome, coma, hypotension, hypoventilation. Clonazepam dosage: . During the same period patient was treated with PROPRANOLOL (View Propranolol Review and Propranolol Label ). Patient was hospitalized.

6640216-7 | Bone Development Abnormal, Dysmorphism, Ear Disorder, Microtia, Retrognathia
on Mar 08, 2010 Female patient from FRANCE , weighting 7.72 lb, was diagnosed with epilepsy (What is epilepsy?) and was treated with Clonazepam (View Usage). Patient experienced the following unwanted or unexpected effects: bone development abnormal, dysmorphism, ear disorder, microtia, retrognathia. Clonazepam dosage: . During the same period patient was treated with LAMOTRIGINE (View Lamotrigine Review and Lamotrigine Label ), TOPIRAMATE (View Topiramate Review and Topiramate Label ), OXCARBAZEPINE (View Oxcarbazepine Review and Oxcarbazepine Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ).

6615258-8 | Aggression, Hypertension, Panic Attack
Patient was taking Clonazepam (View Usage). Patient had the following side effects: aggression, hypertension, panic attack on Feb 23, 2010 from UNITED STATES Additional patient health information: Male patient , 24 years of age, weighting 216.0 lb, was diagnosed with anxiety (What is anxiety?), panic attack and. Clonazepam dosage: . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), DOXYCYCLINE HCL (View Doxycycline Hcl Review and Doxycycline Hcl Label ), TRAMADOL HCL (View Tramadol Hcl Review and Tramadol Hcl Label ), DARVOCET N 100 (View Darvocet-n 100 Review and Darvocet-n 100 Label ).

6614907-8 | Completed Suicide
Adverse event was reported on Feb 19, 2010 by a Female patient taking Clonazepam (View Usage) (Dosage: ) . Location: UNITED STATES , 42 years of age, After Clonazepam was administered, patient had the following side effects: completed suicide. During the same period patient was treated with ZOLPIDEM TARTRATE (View Zolpidem Tartrate Review and Zolpidem Tartrate Label ), TRAMADOL HCL (View Tramadol Hcl Review and Tramadol Hcl Label ), CYCLOBENZAPRINE HYDROCHLORIDE (View Cyclobenzaprine Hydrochloride Review and Cyclobenzaprine Hydrochloride Label ), TRAZODONE HCL (View Trazodone Hcl Review and Trazodone Hcl Label ), DULOXETINE HYDROCHLORIDE (View Duloxetine Hydrochloride Review and Duloxetine Hydrochloride Label ).

6611588-4 | Aphasia, Bedridden, Dizziness, Fatigue, Gastrointestinal Disorder, Insomnia, Memory Impairment
on Feb 26, 2010 Female patient from UNITED STATES , 45 years of age, weighting 155.0 lb, was treated with Clonazepam (View Usage). Patient experienced the following unwanted or unexpected effects: aphasia (What is aphasia?), bedridden, dizziness (What is dizziness?), fatigue, gastrointestinal disorder, insomnia, memory impairment. Clonazepam dosage: 2 Mg Once A Day Po.

6609071-5 | Fear, Feeling Abnormal, Hallucination, Restlessness, Tachyphrenia, Withdrawal Syndrome
on Feb 25, 2010 Male patient from UNITED STATES , 45 years of age, weighting 230.0 lb, was diagnosed with tardive dyskinesia and was treated with Clonazepam (View Usage). Patient had the following side effects: fear, feeling abnormal, hallucination, restlessness, tachyphrenia, withdrawal syndrome. Clonazepam dosage: 1 Nightly Po.

6608617-0 | Ataxia, Drooling, Sedation
Patient was taking Clonazepam (View Usage). After Clonazepam was administered, patient had the following side effects: ataxia (What is ataxia?), drooling, sedation on Feb 26, 2010 from UNITED STATES Additional patient health information: Male patient , 24 years of age, weighting 190.0 lb, . Clonazepam dosage: 1mg Po. During the same period patient was treated with COGENTIN (View Cogentin Review and Cogentin Label ), ATROPINE SULFATE (View Atropine Sulfate Review and Atropine Sulfate Label ), FLUPHENAZINE (View Fluphenazine Review and Fluphenazine Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), CLOZAPINE (View Clozapine Review and Clozapine Label ).

6601135-5 | Panic Attack, Product Substitution Issue
Adverse event was reported on Feb 24, 2010 by a Female patient taking Clonazepam (View Usage) (Dosage: ) was diagnosed with anxiety (What is anxiety?) and. Location: UNITED STATES , 49 years of age, weighting 200.0 lb, Patient experienced the following unwanted or unexpected effects: panic attack, product substitution issue. Patient was hospitalized.

6600498-4 | Anxiety, Condition Aggravated, Injury, Movement Disorder, Product Substitution Issue, Self-injurious Ideation, Speech Disorder, Suicidal Ideation
on Feb 23, 2010 Female patient from UNITED STATES , 36 years of age, weighting 127.0 lb, was diagnosed with anxiety (What is anxiety?) and was treated with Clonazepam (View Usage). Patient had the following side effects: anxiety (What is anxiety?), condition aggravated, injury, movement disorder (What is movement disorder?), product substitution issue, self-injurious ideation, speech disorder, suicidal ideation. Clonazepam dosage: .05 Mg Once/twice Daily Po. Patient was hospitalized.

6597225-6 | Dependence, Migraine, Neck Pain, Withdrawal Syndrome
on Feb 11, 2010 Female patient from UNITED STATES , 69 years of age, weighting 135.0 lb, was diagnosed with irritable bowel syndrome (What is irritable bowel syndrome?) and was treated with Clonazepam (View Usage). After Clonazepam was administered, patient had the following side effects: dependence, migraine (What is migraine?), neck pain, withdrawal syndrome. Clonazepam dosage: .

6594343-3 | Suicide Attempt
Patient was taking Clonazepam (View Usage). Patient experienced the following unwanted or unexpected effects: suicide attempt on Feb 18, 2010 from UNITED STATES Additional patient health information: Male patient , 72 years of age, . Clonazepam dosage: 0.5 Mg Bid Po. Patient was hospitalized.

6588771-X | Atrial Fibrillation
Adverse event was reported on Feb 08, 2010 by a Male patient taking Clonazepam (View Usage) (Dosage: 2 Mg, Qhs) was diagnosed with sleep disorder (What is sleep disorder?) and. Location: CHINA , 74 years of age, Patient had the following side effects: atrial fibrillation (What is atrial fibrillation?). Patient was hospitalized.

6585137-3 | Agitation, Akathisia, Blood Creatinine Increased, Coma Scale Abnormal, Confusional State, Delayed Recovery From Anaesthesia, Disorientation, Hydronephrosis
on Feb 05, 2010 Female patient from UNITED KINGDOM , 39 years of age, weighting 114.6 lb, was diagnosed with induction of anaesthesia and was treated with Clonazepam (View Usage). After Clonazepam was administered, patient had the following side effects: agitation, akathisia, blood creatinine increased, coma scale abnormal, confusional state, delayed recovery from anaesthesia, disorientation, hydronephrosis. Clonazepam dosage: . During the same period patient was treated with FOLIC ACID (View Folic Acid Review and Folic Acid Label ), ISOFLURANE (View Isoflurane Review and Isoflurane Label ), LACTULOSE (View Lactulose Review and Lactulose Label ), OLANZAPINE (View Olanzapine Review and Olanzapine Label ), THIOPENTAL SODIUM (View Thiopental Sodium Review and Thiopental Sodium Label ), AMOXICILLIN AND CLAVULANATE POTASSIUM (View Amoxicillin And Clavulanate Potassium Review and Amoxicillin And Clavulanate Potassium Label ), HARTMANN'S SOLUTION FOR INJECTION (View Hartmann's Solution For Injection Review and Hartmann's Solution For Injection Label ). Patient was hospitalized.

6569593-2 | Agitation, Angioedema, Chest Discomfort, Palpitations
on Jan 24, 2010 Female patient from UNITED STATES , 60 years of age, was diagnosed with neuralgia, migraine (What is migraine?), atrial fibrillation (What is atrial fibrillation?), gastrooesophageal reflux disease and was treated with Clonazepam (View Usage). Patient experienced the following unwanted or unexpected effects: agitation, angioedema, chest discomfort, palpitations. Clonazepam dosage: . During the same period patient was treated with CLIMARA (View Climara Review and Climara Label ), TOPAMAX (View Topamax Review and Topamax Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), NEXIUM (View Nexium Review and Nexium Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), COUMADIN (View Coumadin Review and Coumadin Label ).

6569277-0 | Activities Of Daily Living Impaired, Impaired Work Ability, Insomnia, Sleep Terror
Patient was taking Clonazepam (View Usage). Patient had the following side effects: activities of daily living impaired, impaired work ability, insomnia, sleep terror on Feb 01, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 150.0 lb, was diagnosed with anxiety (What is anxiety?) and. Clonazepam dosage: 1 Mg Q Hs Oral.